BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kayvanpour E, Sedaghat-hamedani F, Amr A, Lai A, Haas J, Holzer DB, Frese KS, Keller A, Jensen K, Katus HA, Meder B. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin Res Cardiol 2017;106:127-39. [DOI: 10.1007/s00392-016-1033-6] [Cited by in Crossref: 110] [Cited by in F6Publishing: 99] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Shen Y, Xu X, Guo G, Chen Y, Wei Q, Li H, He K, Liu C. Genomic and RNA-Seq profiling of patients with HFrEF unraveled OAS1 mutation and aggressive expression. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.11.029] [Reference Citation Analysis]
2 Myasnikov RP, Kulikova OV, Meshkov AN, Bukaeva AA, Kiseleva AV, Ershova AI, Petukhova AV, Divashuk MG, Zotova ED, Sotnikova EA, Abisheva AA, Muraveva AV, Koretskiy SN, Popov SV, Utkina MV, Snigir EA, Mitrofanov SI, Konureeva KD, Mershina EA, Sinitsyn VE, Yudin SM, Drapkina OM. A Splice Variant of the MYH7 Gene Is Causative in a Family with Isolated Left Ventricular Noncompaction Cardiomyopathy. Genes 2022;13:1750. [DOI: 10.3390/genes13101750] [Reference Citation Analysis]
3 Hata Y, Ichimata S, Hirono K, Yamaguchi Y, Oku Y, Ichida F, Nishida N. Pathological and Comprehensive Genetic Investigation of Autopsy Cases of Idiopathic Bradyarrhythmia. Circ J 2022. [PMID: 36070930 DOI: 10.1253/circj.CJ-22-0397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group . 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022:ehac262. [PMID: 36017572 DOI: 10.1093/eurheartj/ehac262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
5 Willemars MMA, Nabben M, Verdonschot JAJ, Hoes MF. Evaluation of the Interaction of Sex Hormones and Cardiovascular Function and Health. Curr Heart Fail Rep 2022. [PMID: 35624387 DOI: 10.1007/s11897-022-00555-0] [Reference Citation Analysis]
6 Lukas Laws J, Lancaster MC, Ben Shoemaker M, Stevenson WG, Hung RR, Wells Q, Marshall Brinkley D, Hughes S, Anderson K, Roden D, Stevenson LW. Arrhythmias as Presentation of Genetic Cardiomyopathy. Circ Res 2022;130:1698-722. [PMID: 35617362 DOI: 10.1161/CIRCRESAHA.122.319835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Manoharan A, Sambandam R, Ballambattu VB. Genetics of atrial fibrillation-an update of recent findings. Mol Biol Rep 2022. [PMID: 35587846 DOI: 10.1007/s11033-022-07420-2] [Reference Citation Analysis]
8 Wilde AAM, Semsarian C, Márquez MF, Sepehri Shamloo A, Ackerman MJ, Ashley EA, Sternick EB, Barajas-Martinez H, Behr ER, Bezzina CR, Breckpot J, Charron P, Chockalingam P, Crotti L, Gollob MH, Lubitz S, Makita N, Ohno S, Ortiz-Genga M, Sacilotto L, Schulze-Bahr E, Shimizu W, Sotoodehnia N, Tadros R, Ware JS, Winlaw DS, Kaufman ES; ESC Scientific Document Group . European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace 2022:euac030. [PMID: 35373836 DOI: 10.1093/europace/euac030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
9 Wilde AAM, Semsarian C, Márquez MF, Shamloo AS, Ackerman MJ, Ashley EA, Sternick EB, Barajas-Martinez H, Behr ER, Bezzina CR, Breckpot J, Charron P, Chockalingam P, Crotti L, Gollob MH, Lubitz S, Makita N, Ohno S, Ortiz-Genga M, Sacilotto L, Schulze-Bahr E, Shimizu W, Sotoodehnia N, Tadros R, Ware JS, Winlaw DS, Kaufman ES; Document Reviewers. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Heart Rhythm 2022:S1547-5271(22)01697-6. [PMID: 35390533 DOI: 10.1016/j.hrthm.2022.03.1225] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
10 Wang L, Qiu B, Yuan M, Zou H, Gong C, Huang H, Lai S, Liu J. Identification and Validation of Dilated Cardiomyopathy-Related Genes via Bioinformatics Analysis. IJGM 2022;Volume 15:3663-76. [DOI: 10.2147/ijgm.s350954] [Reference Citation Analysis]
11 Valenti AC, Albini A, Imberti JF, Vitolo M, Bonini N, Lattanzi G, Schnabel RB, Boriani G. Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature. Biology 2022;11:530. [DOI: 10.3390/biology11040530] [Reference Citation Analysis]
12 Pavez-Giani MG, Cyganek L. Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells. Front Cell Dev Biol 2021;9:800529. [PMID: 35083221 DOI: 10.3389/fcell.2021.800529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Westphal DS, Pollmann K, Marschall C, Wacker-gussmann A, Oberhoffer-fritz R, Laugwitz K, Ewert P, Wolf CM. It Is Not Carved in Stone—The Need for a Genetic Reevaluation of Variants in Pediatric Cardiomyopathies. JCDD 2022;9:41. [DOI: 10.3390/jcdd9020041] [Reference Citation Analysis]
14 Asher C, Puyol-Antón E, Rizvi M, Ruijsink B, Chiribiri A, Razavi R, Carr-White G. The Role of AI in Characterizing the DCM Phenotype. Front Cardiovasc Med 2021;8:787614. [PMID: 34993240 DOI: 10.3389/fcvm.2021.787614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bourfiss M, van Vugt M, Alasiri AI, Ruijsink B, van Setten J, Schmidt AF, Dooijes D, Puyol-antón E, Velthuis BK, van Tintelen JP, te Riele AS, Baas AF, Asselbergs FW. Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population.. [DOI: 10.1101/2022.01.06.22268837] [Reference Citation Analysis]
16 Asano M, Doi K, Nomura M, Nagasaka Y. Cerebral oximetry-guided pulmonary artery banding for end-stage heart failure in a child with left ventricular noncompaction cardiomyopathy: a case report. Transl Pediatr 2021;10:3082-90. [PMID: 34976774 DOI: 10.21037/tp-21-340] [Reference Citation Analysis]
17 Khan RS, Pahl E, Dellefave‐castillo L, Rychlik K, Ing A, Yap KL, Brew C, Johnston JR, Mcnally EM, Webster G. Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy. JAHA. [DOI: 10.1161/jaha.121.022854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 de Feria A, Owens AT. Novel therapies in inherited cardiomyopathies. Progress in Pediatric Cardiology 2021;63:101444. [DOI: 10.1016/j.ppedcard.2021.101444] [Reference Citation Analysis]
19 Sedaghat-Hamedani F, Rebs S, El-Battrawy I, Chasan S, Krause T, Haas J, Zhong R, Liao Z, Xu Q, Zhou X, Akin I, Zitron E, Frey N, Streckfuss-Bömeke K, Kayvanpour E. Identification of SCN5a p.C335R Variant in a Large Family with Dilated Cardiomyopathy and Conduction Disease. Int J Mol Sci 2021;22:12990. [PMID: 34884792 DOI: 10.3390/ijms222312990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 van der Pijl RJ, Domenighetti AA, Sheikh F, Ehler E, Ottenheijm CAC, Lange S. The titin N2B and N2A regions: biomechanical and metabolic signaling hubs in cross-striated muscles. Biophys Rev 2021;13:653-77. [PMID: 34745373 DOI: 10.1007/s12551-021-00836-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
21 Wijchers S, von der Thüsen JH, Robertus JL, Caliskan K. A case with two faces: noncompaction or phospholamban cardiomyopathy?: Noncompaction or phospholamban cardiomyopathy? Cardiovasc Pathol 2021;:107395. [PMID: 34752915 DOI: 10.1016/j.carpath.2021.107395] [Reference Citation Analysis]
22 Pooranachandran V, Nicolson W, Vali Z, Li X, Ng GA. Non-invasive markers for sudden cardiac death risk stratification in dilated cardiomyopathy. Heart 2021:heartjnl-2021-319971. [PMID: 34670824 DOI: 10.1136/heartjnl-2021-319971] [Reference Citation Analysis]
23 Chen XY, Han HF, He ZY, Xu XG. Immune Mechanism, Gene Module, and Molecular Subtype Identification of Astragalus Membranaceus in the Treatment of Dilated Cardiomyopathy: An Integrated Bioinformatics Study. Evid Based Complement Alternat Med 2021;2021:2252832. [PMID: 34567206 DOI: 10.1155/2021/2252832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Koelemen J, Gotthardt M, Steinmetz LM, Meder B. RBM20-Related Cardiomyopathy: Current Understanding and Future Options. J Clin Med 2021;10:4101. [PMID: 34575212 DOI: 10.3390/jcm10184101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Oh J, Lee SH, Choi J, Choi JR, Kim S, Cha YJ, Choi HK, Won D, Yoon HG, Park SW, Kang SM, Lee ST, Lee SH. Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His. Stem Cell Res 2021;56:102508. [PMID: 34438160 DOI: 10.1016/j.scr.2021.102508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Braumann S, Schumacher W, Im NG, Nettersheim FS, Mehrkens D, Bokredenghel S, Hof A, Nies RJ, Adler C, Winkels H, Knöll R, Freeman BA, Rudolph V, Klinke A, Adam M, Baldus S, Mollenhauer M, Geißen S. Nitro-Oleic Acid (NO2-OA) Improves Systolic Function in Dilated Cardiomyopathy by Attenuating Myocardial Fibrosis. Int J Mol Sci 2021;22:9052. [PMID: 34445757 DOI: 10.3390/ijms22169052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Wang Y, Han B, Fan Y, Yi Y, Lv J, Wang J, Yang X, Jiang D, Zhao L, Zhang J, Yuan H. Next-Generation Sequencing Reveals Novel Genetic Variants for Dilated Cardiomyopathy in Pediatric Chinese Patients. Pediatr Cardiol 2021. [PMID: 34350506 DOI: 10.1007/s00246-021-02698-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kayvanpour E, Sammani A, Sedaghat-Hamedani F, Lehmann DH, Broezel A, Koelemenoglu J, Chmielewski P, Curjol A, Socie P, Miersch T, Haas J, Gi WT, Richard P, Płoski R, Truszkowska G, Baas AF, Foss-Nieradko B, Michalak E, Stępień-Wojno M, Zakrzewska-Koperska J, Śpiewak M, Zieliński T, Villard E, Te Riele ASJM, Katus HA, Frey N, Bilińska ZT, Charron P, Asselbergs FW, Meder B. A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk). Int J Cardiol 2021;339:75-82. [PMID: 34245791 DOI: 10.1016/j.ijcard.2021.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
29 Onoue K, Wakimoto H, Jiang J, Parfenov M, DePalma S, Conner D, Gorham J, McKean D, Seidman JG, Seidman CE, Saito Y. Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation. Front Cardiovasc Med 2021;8:639148. [PMID: 34250035 DOI: 10.3389/fcvm.2021.639148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Seguret M, Vermersch E, Jouve C, Hulot JS. Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies. Biomedicines 2021;9:563. [PMID: 34069816 DOI: 10.3390/biomedicines9050563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Lennermann D, Backs J, van den Hoogenhof MMG. New Insights in RBM20 Cardiomyopathy. Curr Heart Fail Rep 2020;17:234-46. [PMID: 32789749 DOI: 10.1007/s11897-020-00475-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]
32 Li M, Xia S, Xu L, Tan H, Yang J, Wu Z, He X, Li L. Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy. J Transl Med 2021;19:189. [PMID: 33941202 DOI: 10.1186/s12967-021-02832-3] [Reference Citation Analysis]
33 Chen X, Xie Y, Li X, Gong J, Shen L, Zhang R. A new discovered gene mutation in a child with dilated cardiomyopathy. Cardiol Young 2021;:1-2. [PMID: 33818356 DOI: 10.1017/S1047951121001104] [Reference Citation Analysis]
34 Bertero A. RNA Biogenesis Instructs Functional Inter-Chromosomal Genome Architecture. Front Genet 2021;12:645863. [PMID: 33732290 DOI: 10.3389/fgene.2021.645863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Sammani A, Baas AF, Asselbergs FW, Te Riele ASJM. Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics. J Clin Med 2021;10:921. [PMID: 33652931 DOI: 10.3390/jcm10050921] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
36 Jordà P, Toro R, Diez C, Salazar-Mendiguchía J, Fernandez-Falgueras A, Perez-Serra A, Coll M, Puigmulé M, Arbelo E, García-Álvarez A, Sarquella-Brugada G, Cesar S, Tiron C, Iglesias A, Brugada J, Brugada R, Campuzano O. Malignant Arrhythmogenic Role Associated with RBM20: A Comprehensive Interpretation Focused on a Personalized Approach. J Pers Med 2021;11:130. [PMID: 33671899 DOI: 10.3390/jpm11020130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Vakhrushev Y, Kozyreva A, Semenov A, Sokolnikova P, Lubimtseva T, Lebedev D, Smolina N, Zhuk S, Mitrofanova L, Vasichkina E, Kostareva A. RBM20-Associated Ventricular Arrhythmias in a Patient with Structurally Normal Heart. Genes (Basel) 2021;12:94. [PMID: 33450993 DOI: 10.3390/genes12010094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Micaglio E, Monasky MM, Bernardini A, Mecarocci V, Borrelli V, Ciconte G, Locati ET, Piccoli M, Ghiroldi A, Anastasia L, Pappone C. Clinical Considerations for a Family with Dilated Cardiomyopathy, Sudden Cardiac Death, and a Novel TTN Frameshift Mutation. Int J Mol Sci 2021;22:E670. [PMID: 33445410 DOI: 10.3390/ijms22020670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Robyns T, Willems R, Van Cleemput J, Jhangiani S, Muzny D, Gibbs R, Lupski JR, Breckpot J, Devriendt K, Corveleyn A. Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in RBM20. Acta Cardiol 2020;75:748-53. [PMID: 31583969 DOI: 10.1080/00015385.2019.1674490] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
40 Bertero A, Rosa-Garrido M. Three-dimensional chromatin organization in cardiac development and disease. J Mol Cell Cardiol 2021;151:89-105. [PMID: 33242466 DOI: 10.1016/j.yjmcc.2020.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Asselbergs FW, Sammani A, Elliott P, Gimeno JR, Tavazzi L, Tendera M, Kaski JP, Maggioni AP, Rubis PP, Jurcut R, Heliö T, Calò L, Sinagra G, Zdravkovic M, Olivotto I, Kavoliūnienė A, Laroche C, Caforio ALP, Charron P; Cardiomyopathy & Myocarditis Registry Investigators Group. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry. ESC Heart Fail 2021;8:95-105. [PMID: 33179448 DOI: 10.1002/ehf2.13100] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
42 Zhang C, Genchev GZ, Bergau D, Lu H. Correlations Between Phenotypes and Biological Process Ontologies in Monogenic Human Diseases. Interdiscip Sci 2020;12:547-54. [PMID: 33113078 DOI: 10.1007/s12539-020-00400-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Ihara K, Sasano T, Hiraoka Y, Togo-Ohno M, Soejima Y, Sawabe M, Tsuchiya M, Ogawa H, Furukawa T, Kuroyanagi H. A missense mutation in the RSRSP stretch of Rbm20 causes dilated cardiomyopathy and atrial fibrillation in mice. Sci Rep 2020;10:17894. [PMID: 33110103 DOI: 10.1038/s41598-020-74800-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
44 Wilsbacher LD. Clinical Implications of the Genetic Architecture of Dilated Cardiomyopathy. Curr Cardiol Rep 2020;22:170. [PMID: 33040239 DOI: 10.1007/s11886-020-01423-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Jiang X, Xu Y, Sun J, Wang L, Guo X, Chen Y. The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family. Sci Rep 2020;10:16478. [PMID: 33020536 DOI: 10.1038/s41598-020-73359-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Yeung C, Enriquez A, Suarez-Fuster L, Baranchuk A. Atrial fibrillation in patients with inherited cardiomyopathies. Europace 2019;21:22-32. [PMID: 29684120 DOI: 10.1093/europace/euy064] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
47 Upadhyay SK, Mackereth CD. Structural basis of UCUU RNA motif recognition by splicing factor RBM20. Nucleic Acids Res 2020;48:4538-50. [PMID: 32187365 DOI: 10.1093/nar/gkaa168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
48 Rieder M, Castiglione A, Asatryan B, Odening KE. Welche Bedeutung hat die Genetik in der Rhythmologie? Herzschr Elektrophys 2020;31:394-400. [DOI: 10.1007/s00399-020-00697-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Asatryan B, Chahal CAA. Enhancing risk stratification for life-threatening ventricular arrhythmias in dilated cardiomyopathy: the peril and promise of precision medicine. ESC Heart Fail 2020;7:1383-6. [PMID: 32643283 DOI: 10.1002/ehf2.12886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Crasto S, My I, Di Pasquale E. The Broad Spectrum of LMNA Cardiac Diseases: From Molecular Mechanisms to Clinical Phenotype. Front Physiol 2020;11:761. [PMID: 32719615 DOI: 10.3389/fphys.2020.00761] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
51 Mansueto G, Benincasa G, Della Mura N, Nicoletti GF, Napoli C. Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs. J Clin Pathol 2020;73:535-43. [DOI: 10.1136/jclinpath-2019-206404] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
52 Hänselmann A, Veltmann C, Bauersachs J, Berliner D. Dilated cardiomyopathies and non-compaction cardiomyopathy. Herz 2020;45:212-20. [PMID: 32107565 DOI: 10.1007/s00059-020-04903-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
53 Tsalamandris S, Oikonomou E, Vogiatzi G, Miliou A, Lazaros G, Georgakopoulos C, Gialafos E, Sideris S, Vlachopoulos C, Tousoulis D. X-linked dilated cardiomyopathy: the important role of genetic tests and imaging in the early diagnosis and treatment. Future Cardiol 2020;16:629-34. [PMID: 32508136 DOI: 10.2217/fca-2020-0030] [Reference Citation Analysis]
54 Quiat D, Witkowski L, Zouk H, Daly KP, Roberts AE. Retrospective Analysis of Clinical Genetic Testing in Pediatric Primary Dilated Cardiomyopathy: Testing Outcomes and the Effects of Variant Reclassification. J Am Heart Assoc 2020;9:e016195. [PMID: 32458740 DOI: 10.1161/JAHA.120.016195] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
55 Gi WT, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Tappu R, Lehmann DH, Shirvani Samani O, Wisdom M, Keller A, Katus HA, Meder B. Epigenetic Regulation of Alternative mRNA Splicing in Dilated Cardiomyopathy. J Clin Med 2020;9:E1499. [PMID: 32429430 DOI: 10.3390/jcm9051499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
56 Arvanitaki A, Michou E, Kalogeropoulos A, Karvounis H, Giannakoulas G. Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations. ESC Heart Fail 2020;7:1477-87. [PMID: 32368873 DOI: 10.1002/ehf2.12701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Sammani A, Kayvanpour E, Bosman LP, Sedaghat-Hamedani F, Proctor T, Gi WT, Broezel A, Jensen K, Katus HA, Te Riele ASJM, Meder B, Asselbergs FW. Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta-analysis and systematic review. ESC Heart Fail 2020;7:1430-41. [PMID: 32285648 DOI: 10.1002/ehf2.12689] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
58 Fochi S, Lorenzi P, Galasso M, Stefani C, Trabetti E, Zipeto D, Romanelli MG. The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases. Genes (Basel) 2020;11:E402. [PMID: 32276354 DOI: 10.3390/genes11040402] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
59 Rahm AK, Lugenbiel P, Ochs M, Meder B, Thomas D, Katus HA, Scholz E. Pulmonary vein isolation treats symptomatic AF in a patient with Lamin A/C mutation: case report and review of the literature. Clin Res Cardiol 2020;109:1070-5. [PMID: 32144494 DOI: 10.1007/s00392-020-01616-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Zhang XL, Xie J, Lan RF, Kang LN, Wang L, Xu W, Xu B. Genetic Basis and Genotype-Phenotype Correlations in Han Chinese Patients with Idiopathic Dilated Cardiomyopathy. Sci Rep 2020;10:2226. [PMID: 32041989 DOI: 10.1038/s41598-020-58984-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
61 Parrott A, Khoury PR, Shikany AR, Lorts A, Villa CR, Miller EM. Investigation of de novo variation in pediatric cardiomyopathy. Am J Med Genet C Semin Med Genet 2020;184:116-23. [PMID: 31912959 DOI: 10.1002/ajmg.c.31764] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
62 Alimadadi A, Munroe PB, Joe B, Cheng X. Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets. Genes (Basel) 2020;11:E60. [PMID: 31948008 DOI: 10.3390/genes11010060] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
63 Paranal RM, Teekakirikul P, Ho CY, Fatkin D, Seidman CE. Genetic Cardiomyopathies. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2020. [DOI: 10.1016/b978-0-12-812532-8.00002-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Proost VM, Wilde AA. Arrhythmogenic Cardiomyopathy. Electrocardiography of Inherited Arrhythmias and Cardiomyopathies 2020. [DOI: 10.1007/978-3-030-52173-8_7] [Reference Citation Analysis]
65 Wang B, Lunetta KL, Dupuis J, Lubitz SA, Trinquart L, Yao L, Ellinor PT, Benjamin EJ, Lin H. Integrative Omics Approach to Identifying Genes Associated With Atrial Fibrillation. Circ Res 2020;126:350-60. [PMID: 31801406 DOI: 10.1161/CIRCRESAHA.119.315179] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
66 Fatkin D, Huttner IG, Kovacic JC, Seidman J, Seidman CE. Precision Medicine in the Management of Dilated Cardiomyopathy. Journal of the American College of Cardiology 2019;74:2921-38. [DOI: 10.1016/j.jacc.2019.10.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
67 Kiselev AM, Vershinina TL, Tarnovskaya SI, Yakovleva EV, Butish L, Fomicheva YV, Fedotov PA, Kozyreva AA, Vakhrushev YA, Latypov AK, Morozov AА, Kozyrev IA, Pervunina TM, Vasichkina ES, Kostareva AA. Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy. Russ J Cardiol 2019. [DOI: 10.15829/1560-4071-2019-10-92-99] [Reference Citation Analysis]
68 Upadhyay SK, Mackereth CD. Structural basis of UCUU RNA motif recognition by splicing factor RBM20.. [DOI: 10.1101/823351] [Reference Citation Analysis]
69 Kühnisch J, Herbst C, Al-Wakeel-Marquard N, Dartsch J, Holtgrewe M, Baban A, Mearini G, Hardt J, Kolokotronis K, Gerull B, Carrier L, Beule D, Schubert S, Messroghli D, Degener F, Berger F, Klaassen S. Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3. Clin Genet 2019;96:549-59. [PMID: 31568572 DOI: 10.1111/cge.13645] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
70 Rieger AC, Myerburg RJ, Florea V, Tompkins BA, Natsumeda M, Premer C, Khan A, Schulman IH, Vidro-Casiano M, DiFede DL, Heldman AW, Mitrani R, Hare JM. Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy. EBioMedicine 2019;48:377-85. [PMID: 31648988 DOI: 10.1016/j.ebiom.2019.09.043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
71 Glöcklhofer CR, Steinfurt J, Franke G, Hoppmann A, Glantschnig T, Perez-Feliz S, Alter S, Fischer J, Brunner M, Rainer PP, Köttgen A, Bode C, Odening KE. A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family. Europace 2018;20:2003-13. [PMID: 29947763 DOI: 10.1093/europace/euy127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
72 Lamounier Júnior A, Ferrari F, Max R, Ritt LEF, Stein R. Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice. Arq Bras Cardiol 2019;113:274-81. [PMID: 31483024 DOI: 10.5935/abc.20190144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Verdonschot JAJ, Hazebroek MR, Wang P, Sanders-van Wijk S, Merken JJ, Adriaansen YA, van den Wijngaard A, Krapels IPC, Brunner-La Rocca HP, Brunner HG, Heymans SRB. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy. Circ Heart Fail 2018;11:e005220. [PMID: 30571196 DOI: 10.1161/CIRCHEARTFAILURE.118.005220] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
74 Fang HJ, Liu BP. Prevalence of TTN mutations in patients with dilated cardiomyopathy : A meta-analysis. Herz 2020;45:29-36. [PMID: 31209521 DOI: 10.1007/s00059-019-4825-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
75 Verdonschot JAJ, Hazebroek MR, Ware JS, Prasad SK, Heymans SRB. Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach. J Am Heart Assoc 2019;8:e012514. [PMID: 31433726 DOI: 10.1161/JAHA.119.012514] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
76 Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD, Hsu DT, Lin KY, Price JF, Wilkinson JD, Colan SD. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation 2019;140:e9-e68. [PMID: 31132865 DOI: 10.1161/CIR.0000000000000682] [Cited by in Crossref: 99] [Cited by in F6Publishing: 106] [Article Influence: 33.0] [Reference Citation Analysis]
77 Vaykhanskaya TG, Sivitskaya LN, Kurushko TV, Levdansky OD, Danilenko NG. Dilated cardiomyopathy: reconceptualization of the problem. Russ J Cardiol 2019. [DOI: 10.15829/1560-4071-2019-4-35-47] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
78 Sousa A, Canedo P, Campelo M, Moura B, Leite S, Baixia M, Belo A, Rocha-Gonçalves F, Machado JC, Silva-Cardoso J, Martins E, Fatima Investigators. Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing? Cardiol Res Pract 2019;2019:2743650. [PMID: 31179125 DOI: 10.1155/2019/2743650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Peña-peña ML, Monserrat L. Papel de la genética en la estratificación del riesgo de pacientes con miocardiopatía dilatada no isquémica. Revista Española de Cardiología 2019;72:333-40. [DOI: 10.1016/j.recesp.2018.10.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
80 Li Z, Chen P, Xu J, Yu B, Li X, Wang DW, Wang DW. A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode. International Journal of Cardiology 2019;279:122-5. [DOI: 10.1016/j.ijcard.2018.12.075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
81 Peña-Peña ML, Monserrat L. Risk Stratification in Patients With Nonisquemic Dilated Cardiomyopathy. The Role of Genetic Testing. Rev Esp Cardiol (Engl Ed) 2019;72:333-40. [PMID: 30792015 DOI: 10.1016/j.rec.2018.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Sousa A, Canedo P, Azevedo O, Lopes L, Pinho T, Baixia M, Rocha-gonçalves F, Gonçalves L, Cardoso JS, Machado JC, Martins E. Molecular characterization of Portuguese patients with dilated cardiomyopathy. Revista Portuguesa de Cardiologia (English Edition) 2019;38:129-139. [DOI: 10.1016/j.repce.2018.10.010] [Reference Citation Analysis]
83 Sousa A, Canedo P, Azevedo O, Lopes L, Pinho T, Baixia M, Rocha-gonçalves F, Gonçalves L, Cardoso JS, Machado JC, Martins E. Molecular characterization of Portuguese patients with dilated cardiomyopathy. Revista Portuguesa de Cardiologia 2019;38:129-39. [DOI: 10.1016/j.repc.2018.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
84 Gerull B, Klaassen S, Brodehl A. The Genetic Landscape of Cardiomyopathies. Genetic Causes of Cardiac Disease 2019. [DOI: 10.1007/978-3-030-27371-2_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Hershkovitz T, Kurolap A, Ruhrman-Shahar N, Monakier D, DeChene ET, Peretz-Amit G, Funke B, Zucker N, Hirsch R, Tan WH, Baris Feldman H. Clinical diversity of MYH7-related cardiomyopathies: Insights into genotype-phenotype correlations. Am J Med Genet A 2019;179:365-72. [PMID: 30588760 DOI: 10.1002/ajmg.a.61017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
86 Weidner K, Behnes M, Schupp T, Rusnak J, Reiser L, Taton G, Reichelt T, Ellguth D, Engelke N, Bollow A, El-battrawy I, Ansari U, Hoppner J, Nienaber CA, Mashayekhi K, Weiß C, Akin M, Borggrefe M, Akin I. Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest. Clin Res Cardiol 2019;108:669-82. [DOI: 10.1007/s00392-018-1396-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
87 Watanabe T, Kimura A, Kuroyanagi H. Alternative Splicing Regulator RBM20 and Cardiomyopathy. Front Mol Biosci 2018;5:105. [PMID: 30547036 DOI: 10.3389/fmolb.2018.00105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
88 Hu Z, Zou D. Genotype-phenotype associations in atrial fibrillation: meta-analysis. J Interv Card Electrophysiol 2019;54:283-8. [PMID: 30448967 DOI: 10.1007/s10840-018-0484-2] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
89 Hong X, Lin J, Gu W. Risk factors and therapies in vascular diseases: An umbrella review of updated systematic reviews and meta‐analyses. J Cell Physiol 2019;234:8221-32. [DOI: 10.1002/jcp.27633] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
90 Chaloupka A, Piherova L, Grochova I, Binova J, Krejci J, Spinarova L, Stranecky V, Kmoch S, Kubanek M. Genetic architecture of recent-onset dilated cardiomyopathy in Moravian region assessed by whole-exome sequencing and its clinical correlates. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2019;163:309-17. [PMID: 30275597 DOI: 10.5507/bp.2018.054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
91 Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, Macdonald PS, Hopper I, Kistler PM, Briffa T, Wong J, Abhayaratna W, Thomas L, Audehm R, Newton P, O'loughlin J, Branagan M, Connell C. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart, Lung and Circulation 2018;27:1123-208. [DOI: 10.1016/j.hlc.2018.06.1042] [Cited by in Crossref: 196] [Cited by in F6Publishing: 203] [Article Influence: 49.0] [Reference Citation Analysis]
92 Asatryan B, Medeiros-Domingo A. Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies. J Mol Med (Berl) 2018;96:993-1024. [PMID: 30128729 DOI: 10.1007/s00109-018-1685-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
93 Haghikia A, Schwab J, Vogel-Claussen J, Berliner D, Pfeffer T, König T, Zwadlo C, Moulig VA, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kühl U, Podewski E, Kindermann I, Böhm M, Sliwa K, Hilfiker-Kleiner D, Bauersachs J. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction. Clin Res Cardiol 2019;108:290-7. [PMID: 30121697 DOI: 10.1007/s00392-018-1355-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
94 Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, Lai A, Frese K, Pribe-Wolferts R, Amr A, Li DT, Samani OS, Carstensen A, Bordalo DM, Müller M, Fischer C, Shao J, Wang J, Nie M, Yuan L, Haßfeld S, Schwartz C, Zhou M, Zhou Z, Shu Y, Wang M, Huang K, Zeng Q, Cheng L, Fehlmann T, Ehlermann P, Keller A, Dieterich C, Streckfuß-Bömeke K, Liao Y, Gotthardt M, Katus HA, Meder B. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J 2017;38:3449-60. [PMID: 29029073 DOI: 10.1093/eurheartj/ehx545] [Cited by in Crossref: 115] [Cited by in F6Publishing: 125] [Article Influence: 28.8] [Reference Citation Analysis]
95 Zahr HC, Jaalouk DE. Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy. Front Genet 2018;9:231. [PMID: 30050558 DOI: 10.3389/fgene.2018.00231] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
96 Adadi N, Radi FZ, Lahrouchi N, Hara L, Ratbi I, Elalaoui SC, Alders M, Zarzur J, Bezzina C, Sefiani A. Inherited dilated cardiomyopathy in a large Moroccan family caused by LMNA mutation. Anatol J Cardiol 2018;20:65-8. [PMID: 29952368 DOI: 10.14744/AnatolJCardiol.2018.69639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
97 Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, Morales A, Taylor MRG, Vatta M, Ware SM;  ACMG Professional Practice and Guidelines Committee. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20:899-909. [PMID: 29904160 DOI: 10.1038/s41436-018-0039-z] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 27.0] [Reference Citation Analysis]
98 Horvat C, Johnson R, Lam L, Munro J, Mazzarotto F, Roberts AM, Herman DS, Parfenov M, Haghighi A, McDonough B, DePalma SR, Keogh AM, Macdonald PS, Hayward CS, Roberts A, Barton PJR, Felkin LE, Giannoulatou E, Cook SA, Seidman JG, Seidman CE, Fatkin D. A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy. Genet Med 2019;21:133-43. [PMID: 29892087 DOI: 10.1038/s41436-018-0036-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
99 Ganga HV, Maan A, Kevin Heist E. Should Primary Prevention ICDs Still Be Placed in Patients with Non-ischemic Cardiomyopathy? A Review of the Evidence. Curr Cardiol Rep 2018;20:31. [PMID: 29574588 DOI: 10.1007/s11886-018-0974-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, Morales A, Taylor MRG, Vatta M, Ware SM. Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. J Card Fail. 2018;24:281-302. [PMID: 29567486 DOI: 10.1016/j.cardfail.2018.03.004] [Cited by in Crossref: 192] [Cited by in F6Publishing: 202] [Article Influence: 48.0] [Reference Citation Analysis]
101 Atteya G, Lampert R. Sudden Cardiac Death in Genetic Cardiomyopathies. Card Electrophysiol Clin 2017;9:581-603. [PMID: 29173404 DOI: 10.1016/j.ccep.2017.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
102 Sedaghat-hamedani F, Katus HA, Meder B. Precision medicine for cardiovascular disease: Learning lessons from cardiomyopathies. Herz 2018;43:123-30. [DOI: 10.1007/s00059-017-4667-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
103 Captur G, Arbustini E, Bonne G, Syrris P, Mills K, Wahbi K, Mohiddin SA, Mckenna WJ, Pettit S, Ho CY, Muchir A, Gissen P, Elliott PM, Moon JC. Lamin and the heart. Heart 2018;104:468-79. [DOI: 10.1136/heartjnl-2017-312338] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 15.2] [Reference Citation Analysis]
104 Pankuweit S. Lamin A/C mutations in patients with dilated cardiomyopathy. European Heart Journal 2018;39:861-3. [DOI: 10.1093/eurheartj/ehx650] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
105 Robyns T, Kuiperi C, Breckpot J, Devriendt K, Souche E, Van Cleemput J, Willems R, Nuyens D, Matthijs G, Corveleyn A. Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy. Eur J Hum Genet 2017;25:1313-23. [PMID: 29255176 DOI: 10.1038/s41431-017-0004-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
106 van der Linde IHM, Hiemstra YL, Bökenkamp R, van Mil AM, Breuning MH, Ruivenkamp C, Ten Broeke SW, Veldkamp RF, van Waning JI, van Slegtenhorst MA, van Spaendonck-Zwarts KY, Lekanne Deprez RH, Herkert JC, Boven L, van der Zwaag PA, Jongbloed JDH, Bootsma M, Barge-Schaapveld DQCM. A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects. Neth Heart J 2017;25:675-81. [PMID: 28864942 DOI: 10.1007/s12471-017-1037-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
107 Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Clin Res Cardiol 2018;107:30-41. [PMID: 28840316 DOI: 10.1007/s00392-017-1155-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 12.8] [Reference Citation Analysis]
108 Filonenko K, Katus HA, Meder B. Precision medicine approach to genetic cardiomyopathy. Herz 2017;42:468-75. [PMID: 28653114 DOI: 10.1007/s00059-017-4592-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
109 Manolis AS. Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge. Expert Rev Cardiovasc Ther 2017;15:315-25. [PMID: 28292197 DOI: 10.1080/14779072.2017.1307735] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]